NO2639780T3 - - Google Patents

Info

Publication number: NO2639780T3
Authority: NO; Norway

Application number

NO13001311A

Other languages

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-09-12

Filing date

2013-03-15

Publication date

2018-06-23

2013-03-15 Application filed filed Critical

2018-06-23 Publication of NO2639780T3 publication Critical patent/NO2639780T3/no

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
- C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO13001311A 2011-09-12 2013-03-15 NO2639780T3 (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201161533606P	2011-09-12	2011-09-12

Publications (1)

Publication Number	Publication Date
NO2639780T3 true NO2639780T3 (pt)	2018-06-23

Family

ID=46964039

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO13001311A NO2639780T3 (pt)	2011-09-12	2013-03-15

Country Status (25)

Country	Link
US (3)	US9321760B2 (pt)
EP (1)	EP2755958B9 (pt)
JP (1)	JP6082011B2 (pt)
KR (1)	KR101992505B1 (pt)
CN (2)	CN106946796B (pt)
AU (2)	AU2012308681B2 (pt)
BR (1)	BR112014005468A2 (pt)
CA (1)	CA2844704C (pt)
DK (1)	DK2755958T3 (pt)
EA (1)	EA028057B1 (pt)
ES (1)	ES2646759T3 (pt)
HK (1)	HK1198168A1 (pt)
HR (1)	HRP20171655T1 (pt)
HU (1)	HUE034979T2 (pt)
IL (2)	IL231381B (pt)
LT (1)	LT2755958T (pt)
MX (1)	MX347241B (pt)
NO (1)	NO2639780T3 (pt)
PL (1)	PL2755958T3 (pt)
PT (1)	PT2755958T (pt)
RS (1)	RS56486B1 (pt)
SG (1)	SG2014009260A (pt)
SI (1)	SI2755958T1 (pt)
WO (1)	WO2013040044A1 (pt)
ZA (1)	ZA201401007B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN106831732B (zh)	2011-06-10	2019-12-24	默克专利有限公司	生产具有btk抑制活性的嘧啶和吡啶化合物的组合物和方法
ES2646759T3 (es) *	2011-09-12	2017-12-15	Merck Patent Gmbh	Derivados de aminopirimidina para uso como moduladores de la actividad de la quinasa
JP6386467B2 (ja)	2012-11-16	2018-09-05	メルクパテントゲゼルシャフトミットベシュレンクテルハフツングＭｅｒｃｋＰａｔｅｎｔＧｅｓｅｌｌｓｃｈａｆｔｍｉｔｂｅｓｃｈｒａｅｎｋｔｅｒＨａｆｔｕｎｇ	キナーゼ活性のモジュレーターとしての新規複素環式誘導体
ES2746756T3 (es)	2013-03-11	2020-03-06	Merck Patent Gmbh	Derivados de 6-[4-(1H-imidazol-2-il)piperidin-1-il]pirimidin-4-amina como moduladores de la actividad cinasa
WO2015107494A1 (en)	2014-01-17	2015-07-23	Novartis Ag	1 -(triazin-3-yi_/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions thereof for inhibiting the activity of shp2
JO3517B1 (ar)	2014-01-17	2020-07-05	Novartis Ag	ان-ازاسبيرو الكان حلقي كبديل مركبات اريل-ان مغايرة وتركيبات لتثبيط نشاط shp2
EP3094627B1 (en)	2014-01-17	2018-08-22	Novartis AG	1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and and compositions thereof for inhibiting the activity of shp2
US9434714B2 (en) *	2014-02-11	2016-09-06	Merck Patent Gmbh	Pyrimidine imidazole amines as modulators of kinase activity
EP2939514B1 (en)	2014-04-30	2018-09-05	LG Electronics Inc.	Lawn mower robot and control method thereof
WO2015181532A1 (en) *	2014-05-28	2015-12-03	Astrazeneca Ab	Processes for the preparation of azd5363 and novel intermediate used therein
CN112625028A (zh)	2015-06-19	2021-04-09	诺华股份有限公司	用于抑制shp2活性的化合物和组合物
WO2016203404A1 (en)	2015-06-19	2016-12-22	Novartis Ag	Compounds and compositions for inhibiting the activity of shp2
ES2824576T3 (es)	2015-06-19	2021-05-12	Novartis Ag	Compuestos y composiciones para inhibir la actividad de SHP2
US10829484B2 (en)	2015-07-28	2020-11-10	Plexxikon Inc.	Compounds and methods for kinase modulation, and indications therefor
AU2017232610B2 (en) *	2016-03-16	2021-07-22	Plexxikon Inc.	Compounds and methods for kinase modulation and indications therefore
ES2810852T3 (es)	2016-06-14	2021-03-09	Novartis Ag	Compuestos y composiciones para inhibir la actividad de shp2
CN109467538A (zh)	2017-09-07	2019-03-15	和记黄埔医药（上海）有限公司	环烯烃取代的杂芳环类化合物及其用途
US11369608B2 (en)	2017-10-27	2022-06-28	University Of Virginia Patent Foundation	Compounds and methods for regulating, limiting, or inhibiting AVIL expression
WO2020223715A1 (en) *	2019-05-02	2020-11-05	University Of Virginia Patent Foundation	Substituted (piperidin-1-yl)aryl analogues for modulating avilactivity
US11866421B2 (en)	2021-05-31	2024-01-09	Epigen Biosciences, Inc.	Pyrimidine and pyridine amine compounds and usage thereof in disease treatment

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020137755A1 (en) *	2000-12-04	2002-09-26	Bilodeau Mark T.	Tyrosine kinase inhibitors
TW200306819A (en)	2002-01-25	2003-12-01	Vertex Pharma	Indazole compounds useful as protein kinase inhibitors
CA2522595A1 (en)	2003-04-03	2004-10-28	Vertex Pharmaceuticals Incorporated	Compositions useful as inhibitors of protein kinases
US7189729B2 (en)	2003-09-30	2007-03-13	Irm Llc	Methods and compositions as protein kinase inhibitors
JP4800216B2 (ja)	2003-10-24	2011-10-26	エグゼリクシス，インコーポレイテッド	ｐ７０Ｓ６キナーゼモジュレーターおよび使用方法
ATE400573T1 (de)	2003-11-21	2008-07-15	Novartis Pharma Gmbh	1h-imidazochinolinderivate als proteinkinaseinhibitoren
EP1684694A2 (en) *	2003-11-21	2006-08-02	Array Biopharma, Inc.	Akt protein kinase inhibitors
CA2546920A1 (en)	2003-12-09	2005-06-23	Joel Moss	Methods for suppressing an immune response or treating a proliferative disorder
US8076338B2 (en)	2004-04-23	2011-12-13	Exelixis, Inc.	Kinase modulators and methods of use
US7994172B2 (en)	2004-12-28	2011-08-09	Exelixis, Inc.	[1H-pyrazolo[3, 4-D]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-theoronine kinase modulators (P70s6k, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseases
AU2006206246A1 (en)	2005-01-19	2006-07-27	Neurogen Corporation	Heteroaryl substituted piperazinyl-pyridine analogues
GB0501999D0 (en)	2005-02-01	2005-03-09	Sentinel Oncology Ltd	Pharmaceutical compounds
JP2008546751A (ja)	2005-06-22	2008-12-25	アステックス・セラピューティクス・リミテッド	医薬組成物
EP3719018A1 (en) *	2006-04-25	2020-10-07	Astex Therapeutics Ltd	Purine and deazapurine derivatives as pharmaceutical compounds
WO2008012635A2 (en) *	2006-07-26	2008-01-31	Pfizer Products Inc.	Amine derivatives useful as anticancer agents
US8044041B2 (en) *	2006-11-15	2011-10-25	Forest Laboratories Holdings Limited	Phthalazine derivatives as inhibitors of protein kinase
CA2672373C (en) *	2006-12-19	2011-08-30	Pfizer Products Inc.	Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
UA99284C2 (ru)	2007-05-11	2012-08-10	Елі Ліллі Енд Компані	ИНГИБИТОРЫ р70 S6-КИНАЗЫ
AR074072A1 (es)	2008-11-11	2010-12-22	Lilly Co Eli	Compuesto de imidazol -piperidin -pirrol-pirimidin-6-ona, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para tratar el glioblastoma multiforme
PT2396307E (pt)	2009-02-11	2015-02-04	Merck Patent Gmbh	Novas carboxamidas azaheterocíclicas de amino
WO2011029043A1 (en) *	2009-09-04	2011-03-10	Biogen Idec Ma Inc.	Heteroaryl btk inhibitors
SG186199A1 (en)	2010-07-29	2013-01-30	Merck Patent Gmbh	Cyclic amine azaheterocyclic carboxamides
UA110113C2 (xx)	2010-07-29	2015-11-25		Біциклічні азагетероциклічні карбоксаміди
PT2643313T (pt)	2010-11-24	2016-10-11	Merck Patent Gmbh	Quinazolina carboxamida azetidinas
DK2755965T3 (en) *	2011-09-12	2017-09-25	Merck Patent Gmbh	PRESENT UNKNOWN IMIDAZOLAMINES AS MODULATORS OF KINASE ACTIVITY
ES2646759T3 (es) *	2011-09-12	2017-12-15	Merck Patent Gmbh	Derivados de aminopirimidina para uso como moduladores de la actividad de la quinasa
AU2013344549B2 (en) *	2012-11-16	2018-03-08	Xiaoling Chen	Novel imidazol-piperidinyl derivatives as modulators of kinase activity
US9434714B2 (en) *	2014-02-11	2016-09-06	Merck Patent Gmbh	Pyrimidine imidazole amines as modulators of kinase activity

2012
- 2012-09-12 ES ES12766773.1T patent/ES2646759T3/es active Active
- 2012-09-12 JP JP2014530756A patent/JP6082011B2/ja not_active Expired - Fee Related
- 2012-09-12 EA EA201400338A patent/EA028057B1/ru not_active IP Right Cessation
- 2012-09-12 BR BR112014005468A patent/BR112014005468A2/pt not_active IP Right Cessation
- 2012-09-12 EP EP12766773.1A patent/EP2755958B9/en active Active
- 2012-09-12 CA CA2844704A patent/CA2844704C/en not_active Expired - Fee Related
- 2012-09-12 AU AU2012308681A patent/AU2012308681B2/en not_active Ceased
- 2012-09-12 CN CN201710022892.9A patent/CN106946796B/zh active Active
- 2012-09-12 KR KR1020147007739A patent/KR101992505B1/ko active IP Right Grant
- 2012-09-12 SI SI201231118T patent/SI2755958T1/sl unknown
- 2012-09-12 MX MX2014002836A patent/MX347241B/es active IP Right Grant
- 2012-09-12 LT LTEP12766773.1T patent/LT2755958T/lt unknown
- 2012-09-12 WO PCT/US2012/054877 patent/WO2013040044A1/en active Application Filing
- 2012-09-12 US US14/236,405 patent/US9321760B2/en not_active Expired - Fee Related
- 2012-09-12 PT PT127667731T patent/PT2755958T/pt unknown
- 2012-09-12 RS RS20171130A patent/RS56486B1/sr unknown
- 2012-09-12 CN CN201280054959.2A patent/CN103930407B/zh active Active
- 2012-09-12 HU HUE12766773A patent/HUE034979T2/en unknown
- 2012-09-12 DK DK12766773.1T patent/DK2755958T3/en active
- 2012-09-12 PL PL12766773T patent/PL2755958T3/pl unknown
- 2012-09-12 SG SG2014009260A patent/SG2014009260A/en unknown
2013
- 2013-03-15 NO NO13001311A patent/NO2639780T3/no unknown
2014
- 2014-02-10 ZA ZA2014/01007A patent/ZA201401007B/en unknown
- 2014-03-06 IL IL231381A patent/IL231381B/en active IP Right Grant
- 2014-11-19 HK HK14111691.3A patent/HK1198168A1/xx not_active IP Right Cessation
2016
- 2016-03-03 US US15/060,050 patent/US9662330B2/en active Active
2017
- 2017-04-18 US US15/490,370 patent/US10080750B2/en active Active
- 2017-10-09 AU AU2017245469A patent/AU2017245469B2/en not_active Ceased
- 2017-10-30 HR HRP20171655TT patent/HRP20171655T1/hr unknown
2019
- 2019-05-07 IL IL266510A patent/IL266510B/en active IP Right Grant

Also Published As

Publication number	Publication date
CN103930407B (zh)	2019-02-26
BR112014005468A2 (pt)	2017-03-21
US20150126484A1 (en)	2015-05-07
MX2014002836A (es)	2014-05-28
SI2755958T1 (sl)	2017-12-29
PT2755958T (pt)	2017-11-14
HRP20171655T1 (hr)	2017-12-15
IL231381B (en)	2019-05-30
HK1198168A1 (en)	2015-03-13
US20160184308A1 (en)	2016-06-30
JP6082011B2 (ja)	2017-02-15
ZA201401007B (en)	2018-07-25
US10080750B2 (en)	2018-09-25
KR20140062494A (ko)	2014-05-23
EP2755958B1 (en)	2017-08-09
PL2755958T3 (pl)	2017-12-29
CN103930407A (zh)	2014-07-16
AU2017245469B2 (en)	2019-05-23
EA028057B1 (ru)	2017-10-31
IL231381A0 (en)	2014-04-30
CN106946796B (zh)	2020-05-08
KR101992505B1 (ko)	2019-06-24
LT2755958T (lt)	2017-11-10
IL266510B (en)	2021-01-31
US9321760B2 (en)	2016-04-26
AU2012308681A1 (en)	2014-02-27
CN106946796A (zh)	2017-07-14
CA2844704A1 (en)	2013-03-21
AU2017245469A1 (en)	2017-11-02
JP2014527082A (ja)	2014-10-09
CA2844704C (en)	2020-04-28
SG2014009260A (en)	2014-09-26
EP2755958B9 (en)	2018-02-28
IL266510A (en)	2019-07-31
US9662330B2 (en)	2017-05-30
AU2012308681B2 (en)	2017-07-13
WO2013040044A1 (en)	2013-03-21
EA201400338A1 (ru)	2014-12-30
RS56486B1 (sr)	2018-01-31
MX347241B (es)	2017-04-20
US20170217905A1 (en)	2017-08-03
EP2755958A1 (en)	2014-07-23
ES2646759T3 (es)	2017-12-15
DK2755958T3 (en)	2017-09-25
HUE034979T2 (en)	2018-05-02

Publication	Publication Date	Title
BR112013022641A2 (pt)	2017-09-21
AP3853A (pt)	2016-09-30
BR112013031251A2 (pt)	2017-09-12
BR112013027245A2 (pt)	2017-01-03
BR112013023185A2 (pt)	2017-01-03
BR112013022995A2 (pt)	2012-09-13
BR112013017670A2 (pt)	2017-08-15
BR112013027830A2 (pt)	2017-01-03
BR112013028733A2 (pt)	2017-08-29
BR112013027121A2 (pt)	2017-01-03
BR112013027452A2 (pt)	2017-01-03
AP2016009466A0 (pt)	2016-09-30
BR112013031556A2 (pt)	2017-08-29
BR112013032377A2 (pt)	2017-01-03
BR112013032380A2 (pt)	2017-01-03
BR112013032368A2 (pt)	2017-01-03
NO2639780T3 (pt)	2018-06-23
BR112013018949A2 (pt)	2017-09-12
BR112013021637A2 (pt)	2012-11-01
BR112013027836A2 (pt)	2017-01-03
BR112013032392A2 (pt)	2017-01-03
BR112013017878A2 (pt)	2017-08-15
BR112013027871A2 (pt)	2017-01-03
BR112013032394A2 (pt)	2017-01-03
BR112013030734A2 (pt)	2017-04-04